会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • POLYCYCLIC ALCALOID-DERIVATIVES AS NMDA-RECEPTOR ANTAGONISTS
    • 作为NMDA受体拮抗剂的多环类衍生物衍生物
    • WO1997003979A1
    • 1997-02-06
    • PCT/CA1996000468
    • 1996-07-12
    • BIOCHEM PHARMA INC.DIMAIO, JohnDIXIT, Dilip, M.
    • BIOCHEM PHARMA INC.
    • C07D337/16
    • C07C215/44C07D225/08C07D313/20C07D337/16
    • Polycyclic alkaloids of formula (I), wherein R1 is H, C1-6 alkyl, or C6-12 aryl optionally substituted with polar groups; R2 abd R3 are independently H, OH, C1-6 alkyl, -C(NH)-NH2, a positively charged group, or C7-13 aralkyl optionally substituted with NH2, OH, C1-6 alkyl, or halogen; or R2 and R3 together form a 5 to 6 member ring optionally incorporating a heteroatom; R4 is H, C1-6 alkyl, OR6, SR6 or N(R6)2, wherein each R6 is independently H, C1-3 alkyl; X is O, S, SO, SO2, N-R5, or C-(R5)2, wherein each R5 is independently H, C1-6 alkyl, or C7-13 aralkyl optionally interrupted with one or more heteroatom; n is an integer from 0 to 2; m is an integer from 0 to 3; with the proviso that when X is CH2 then R1 is not CH3, R2 and R3 are not both H, R4 is not OH, m is not 3 and n is not 0. That act as antagonists at the ionotropic NMDA (N-methyl-(D)-aspartic acid) receptor.
    • 式(I)的多环生物碱,其中R 1为H,C 1-6烷基或任选被极性基团取代的C 6-12芳基; R2 abd R3独立地为H,OH,C1-6烷基,-C(NH)-NH2,带正电荷的基团或任选被NH 2,OH,C 1-6烷基或卤素取代的C 7-13芳烷基; 或R 2和R 3一起形成任选地加入杂原子的5至6元环; R4是H,C1-6烷基,OR6,SR6或N(R6)2,其中每个R6独立地是H,C1-3烷基; X是O,S,SO,SO 2,N-R 5或C(R 5)2,其中每个R 5独立地是H,C 1-6烷基或任选被一个或多个杂原子中断的C 7-13芳烷基; n为0〜2的整数; m是0至3的整数; 条件是当X是CH 2时,R 1不是CH 3,R 2和R 3不都是H,R 4不是OH,m不是3且n不是0。作为离子型NMDA(N-甲基 - (D)天冬氨酸)受体。
    • 10. 发明申请
    • NOVEL HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF PAIN AND USE THEREOF
    • 用于治疗疼痛和用途的新型杂环化合物
    • WO1997003978A1
    • 1997-02-06
    • PCT/CA1996000467
    • 1996-07-12
    • BIOCHEM PHARMA INC.DIMAIO, John
    • BIOCHEM PHARMA INC.
    • C07D337/16
    • C07C215/44C07D225/08C07D313/20C07D337/16
    • Polycyclic alkaloids of formula (I), wherein R1 is H, C1-6 alkyl, or C6-12 aryl optionally substituted with polar groups; R2 and R3 are independently H, OH, C1-6 alkyl, -C(NH)-NH2, a positively charged group, or C7-13 aralkyl optionally substituted with NH2, OH, C1-6 alkyl, or halogen; or R2 and R3 together form a 5 to 6 member ring optionally incorporating a heteroatom; R4 is H, C1-6 alkyl, OR6, SR6 or N(R6)2, wherein each R6 is independently H, C1-3 alkyl, or halogen; X is O, S, SO, SO2, N-R5, or C-(R5)2, wherein each R5 is independently H, C1-6 alkyl, or C7-13 aralkyl optionally interrupted with one or more heteroatom; n is an integer from 0 to 2; m is an integer from 0 to 3; with the proviso that when X is CH2 then R1 is not CH3, R2 and R3 are not both H, R4 is not OH, m is not 3 and n is not 0. For the treatment of pain and pharmaceutically acceptable compositions comprising those compounds. The compounds of this invention act as agonists at the opiate receptor.
    • 式(I)的多环生物碱,其中R 1为H,C 1-6烷基或任选被极性基团取代的C 6-12芳基; R2和R3独立地是H,OH,C1-6烷基,-C(NH)-NH2,带正电荷的基团或任选被NH 2,OH,C 1-6烷基或卤素取代的C 7-13芳烷基; 或R 2和R 3一起形成任选地加入杂原子的5至6元环; R4是H,C1-6烷基,OR6,SR6或N(R6)2,其中每个R6独立地是H,C1-3烷基或卤素; X是O,S,SO,SO 2,N-R 5或C(R 5)2,其中每个R 5独立地是H,C 1-6烷基或任选被一个或多个杂原子中断的C 7-13芳烷基; n为0〜2的整数; m是0至3的整数; 条件是当X是CH 2时,R 1不是CH 3,R 2和R 3不同时为H,R 4不为OH,m不为3且n不为0.对于用于治疗包含那些化合物的疼痛和药学上可接受的组合物。 本发明化合物作为鸦片剂受体的激动剂。